Antimicrobial Coatings Market Size, Share, Trends, Opportunity and Forecast, 2023-2030 | New Market Study by RationalStat
25 oct. 2023 09h00 HE
|
Rationalstat LLC
Wilmington, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Global Antimicrobial Coatings Market value is calculated US$ 3.9 billion in 2023 and is expected to grow at a significant CAGR of over 9.4% over the...
Retinoblastoma Treatment Market Set to Touch US$ 3.0 Billion by 2030, According to RationalStat Analysis
13 oct. 2023 06h04 HE
|
Rationalstat LLC
Wilmington, Delaware, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Global Retinoblastoma Treatment Market value is US$ 2.2 billion in 2023 and is predicted to rise at a substantial CAGR of 4.5% during the...
Renal Dialysis Market Set to Reach US$ 133.8 Billion by 2030 | Trends, Share, Growth, and Future Scenarios
28 sept. 2023 02h15 HE
|
Rationalstat LLC
Wilmington, Delaware, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Global Renal Dialysis Market was valued at US$ 76.5 billion in 2023 and is expected to grow at a significant CAGR of over 9.8% over the...
[Market Study] Global Covid Testing Kit Market is expected to hit US$ 52.2 billion by 2028, registering a substantial CAGR of over 19.8%, market report by RationalStat
17 août 2023 10h00 HE
|
Rationalstat LLC
Wilmington, Delaware, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Market Scope and Report Overview Organizations that are driving market expansion have been making more developments. For instance, in...
With a CAGR of 11.8%, the Global Rare Disease Drug Market is forecast to reach a Market Value of US$ 270 billion by 2028 – Market Report by RationalStat
26 juil. 2023 08h59 HE
|
Rationalstat LLC
Wilmington, Delaware, July 26, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s analysis, Global Rare Disease Drug Market was estimated at a market value of US$ 192 billion in 2022 and is...
AI in Drug Discovery Market is Expected to Reach $4.0 billion | MarketsandMarkets.
29 mai 2023 08h45 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 29, 2023 (GLOBE NEWSWIRE) -- AI (Artificial Intelligence) is poised to revolutionize the drug discovery industry in the near future, offering immense potential to accelerate and enhance...
IDLife, LLC CEO Josh Paine Continues to Build a Dream Team
17 janv. 2023 17h00 HE
|
IDLife, LLC (idlife.com)
FRISCO, Texas, Jan. 17, 2023 (GLOBE NEWSWIRE) -- IDLife, LLC CEO Josh Paine has appointed Robert White as the new Chief Financial Officer, and Justin Sparks will transition to the company's Chief...
IDLife, LLC Launches One-of-a-Kind Genetics Tool
23 nov. 2022 18h00 HE
|
IDLife, LLC (idlife.com)
FRISCO, Texas, Nov. 23, 2022 (GLOBE NEWSWIRE) -- IDLife self-developed and launched a one-of-a-kind Genetic Action Plan (GAP) tool. The new GAP tool allows IDLife's genetics customers to input their...
Clinical Trial Imaging Market worth $1.4 billion by 2026 - Exclusive Report by MarketsandMarkets™
19 oct. 2022 04h47 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Oct. 19, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Clinical Trial Imaging Market by Software & Services(Operational Imaging, Read Analysis), Modality(CT,...
Golden Triangle Ventures, Inc. Announces Binding LOI to Acquire all Assets and Intellectual Property from Le Pragma, LLC and Provides Additional Corporate Developments
18 mai 2022 08h30 HE
|
Golden Triangle Ventures, Inc.
LAS VEGAS, May 18, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) is pleased to announce that after nearly 10 months of work it...